127 related articles for article (PubMed ID: 4089767)
1. [Treatment of uremic hypogonadism with parlodel].
Kukhtevich AV; Ermolenko VM; Dedov II; Mel'nichenko GA; Gitel' EP
Ter Arkh; 1985; 57(12):39-41. PubMed ID: 4089767
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of uremic hypogonadism and its treatment with parlodel].
Kukhtevich AV; Ermolenko VM; Dedov II; Bunatian AF; Kuznetsova AI
Akush Ginekol (Mosk); 1985 Aug; (9):63-4. PubMed ID: 2933990
[No Abstract] [Full Text] [Related]
3. [Parlodel treatment of hypogonadism in patients with uremia and after kidney transplantation].
Ermolenko VM; Kukhtevich AV; Dedov II; Bunatian AF; Obydena EA
Urol Nefrol (Mosk); 1985; (3):58-62. PubMed ID: 3892830
[No Abstract] [Full Text] [Related]
4. [Uremic hypogonadism syndrome and the possibilities of its treatment].
Tanchev S; Maleeva A; Visheva N
Akush Ginekol (Sofiia); 1988; 27(1):59-64. PubMed ID: 3369661
[No Abstract] [Full Text] [Related]
5. Hyperprolactinaemia and reproductive failure.
Gunaratne M
Ceylon Med J; 1993 Dec; 38(4):181-3. PubMed ID: 8143334
[TBL] [Abstract][Full Text] [Related]
6. Parlodel treatment of uremic hypogonadism in men.
Ermolenko VM; Kukhtevich AV; Dedov II; Bunatian AF; Melnichenko GA; Gitel EP
Nephron; 1986; 42(1):19-22. PubMed ID: 3079888
[TBL] [Abstract][Full Text] [Related]
7. [The comparative characteristics of parlodel, zinc sulfate and recombinant erythropoietin in treating uremic hypogonadism in patients on chronic hemodialysis].
Kukhtevich AV; Ermolenko VM; Dedov II; Gitel' EP; Buniatian AF; Smirnova GA
Ter Arkh; 1992; 64(11):66-70. PubMed ID: 1293848
[No Abstract] [Full Text] [Related]
8. [Hyperprolactinemia. Reproductive consequences].
Austin KL
Rev Med Panama; 1989 Sep; 14(3):121-7. PubMed ID: 2813875
[TBL] [Abstract][Full Text] [Related]
9. [Parlodel in the treatment of hypogonadism in patients with kidney diseases].
Ermolenko VM; Kukhtevich AV; Dedov II
Vestn Akad Med Nauk SSSR; 1985; (11):55-60. PubMed ID: 4090655
[No Abstract] [Full Text] [Related]
10. Hyperprolactinemia and hypogonadism.
Vaidya RA
J Assoc Physicians India; 1993 Nov; 41(11):700-1. PubMed ID: 8005920
[No Abstract] [Full Text] [Related]
11. [Erectile dysfunction secondary to hyperprolactinemia. Apropos of 13 cases].
Abram F; Linke F; Kalfon A; Tchovelidze C; Chelbi N; Arvis G
Prog Urol; 1998 Sep; 8(4):537-41. PubMed ID: 9834517
[TBL] [Abstract][Full Text] [Related]
12. Specific aspects of erectile dysfunction in endocrinology.
Miralles-García JM; García-Díez LC
Int J Impot Res; 2004 Oct; 16 Suppl 2():S10-2. PubMed ID: 15496851
[TBL] [Abstract][Full Text] [Related]
13. [The results of using parlodel in hyperprolactinemia].
Mel'nichenko GA; Gitel' EP; Romantsova TI
Probl Endokrinol (Mosk); 1990; 36(3):29-33. PubMed ID: 2395828
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of compound xuanju capsule combined with bromocriptine on hyperprolactinemia-induced erectile dysfunction].
Bian J; Liu CD; Sun XZ; Deng CH; Huang YP; Ye YL
Zhonghua Nan Ke Xue; 2012 Nov; 18(11):1023-7. PubMed ID: 23214255
[TBL] [Abstract][Full Text] [Related]
15. Long-acting oral bromocriptine (Parlodel SRO) in the treatment of hyperprolactinemia.
Weingrill CO; Mussio W; Moraes CR; Portes E; Castro RC; Lengyel AM
Fertil Steril; 1992 Feb; 57(2):331-5. PubMed ID: 1735484
[TBL] [Abstract][Full Text] [Related]
16. [Role of hyperprolactinemia in the genesis of menstrual cycle disorders and their correction with parlodel].
Manuilova IA; Sotnikova EI
Akush Ginekol (Mosk); 1984 May; (5):15-6. PubMed ID: 6465440
[No Abstract] [Full Text] [Related]
17. Comparison between a slow-release oral preparation of bromocriptine and regular bromocriptine in patients with hyperprolactinemia: a double blind, double dummy study.
Moro M; Maraschini C; Toja P; Masala A; Alagna S; Rovasio PP; Ginanni A; Lancranjan I; Cavagnini F
Horm Res; 1991; 35(3-4):137-41. PubMed ID: 1806467
[TBL] [Abstract][Full Text] [Related]
18. [Parlodel. Mechanism of action and use].
Marova EI; Egart FM; Pronin VS; Mel'nichenko GA
Probl Endokrinol (Mosk); 1985; 31(3):85-92. PubMed ID: 3903743
[No Abstract] [Full Text] [Related]
19. Hyperprolactinemia and impotence.
el-Beheiry A; Souka A; el-Kamshoushi A; Hussein S; el-Sabah K
Arch Androl; 1988; 21(3):211-4. PubMed ID: 3245713
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of lysenyl-forte treatment in acromegaly and hyperprolactinemia syndrome].
Balabolkin MI; Gerasimov GA; Snigireva RIa; Gorokhova TR
Klin Med (Mosk); 1989 Sep; 67(9):89-92. PubMed ID: 2586051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
